Skip to main content
OpenTrials
Completed

NCT Number: NCT04425889

COVID-19 Antibodies Among Healthcare Workers

Observational, point of prevalence study determining the presence of anti-SARS-CoV-2 antibody

Completed

Looking for future studies?

Notify Me

Key information

Conditions

COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections SARS-CoV 2 Virus Diseases

Age range

18 year–99 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Universitario José E. Gonzalez

Monterrey, Nuevo León, 64460, Mexico

About this study

All Healthcare workers (HCW) who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance to contaminated areas were included. They were classified as asymptomatic and pauci-symptomatic. A COVID-19 IgG/IgM rapid test was used for antibody detection, and selected participants were subject to real time polymerase chain reaction (qPCR) for SARS-CoV-2.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All healthcare workers who had entered contaminated areas at least once and that 14 days or more had passed from their first entrance were included

Exclusion criteria

  • Healthcare workers who did not have exposure for more or equal 14 days
  • Healthcare workers who did not wish to participate

Treatment and study plan

COVID-19 IgG/IgM Rapid Test Cassette test (Healgen Scientific, Houston, Texas, USA)

Diagnostic Test

a blood sample is drained for detection of IgG and IgM antibody

Primary outcomes

  1. Presence of antibody

    Time frame: through study completion, an average of 8 weeks

    presence of IgG and/or IgM against SARS-CoV-2

Sponsors and collaborators

Lead sponsor

Hospital Universitario Dr. Jose E. Gonzalez

Other

Registry information

Official study title

Prevalence of SARS-CoV-2 Antibodies Among Healthcare Workers in a COVID-19 Unit

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Jun 11, 2020
Registry last updated
Jun 12, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.